GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Days Payable

Vivoryon Therapeutics NV (FRA:05Y) Days Payable : 0.00 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Days Payable?

Vivoryon Therapeutics NV's average Accounts Payable for the six months ended in Dec. 2023 was €2.09 Mil. Vivoryon Therapeutics NV's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Vivoryon Therapeutics NV's Days Payable or its related term are showing as below:

During the past 13 years, Vivoryon Therapeutics NV's highest Days Payable was 613.49. The lowest was 613.49. And the median was 613.49.

FRA:05Y's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 148.53
* Ranked among companies with meaningful Days Payable only.

Vivoryon Therapeutics NV's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).


Vivoryon Therapeutics NV Days Payable Historical Data

The historical data trend for Vivoryon Therapeutics NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV Days Payable Chart

Vivoryon Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 613.49 - -

Vivoryon Therapeutics NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vivoryon Therapeutics NV's Days Payable

For the Biotechnology subindustry, Vivoryon Therapeutics NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivoryon Therapeutics NV's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivoryon Therapeutics NV's Days Payable distribution charts can be found below:

* The bar in red indicates where Vivoryon Therapeutics NV's Days Payable falls into.



Vivoryon Therapeutics NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vivoryon Therapeutics NV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2.543 + 2.894) / 2 ) / -0.525*365
=2.7185 / -0.525*365
=N/A

Vivoryon Therapeutics NV's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (1.291 + 2.894) / 2 ) / 0*365 / 2
=2.0925 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivoryon Therapeutics NV Days Payable Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines